SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950129-08-002919
Filing Date
2008-05-12
Accepted
2008-05-09 18:54:31
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q h56654e10vq.htm 10-Q 172142
2 CERTIFICATION PURSUANT TO SECTION 302 (CHIEF EXECUTIVE OFFICER) h56654exv31w1.htm EX-31.1 6052
3 CERTIFICATION PURSUANT TO SECTION 302 (CHIEF FINANCIAL OFFICER) h56654exv31w2.htm EX-31.2 6072
4 CERTIFICATION PURSUANT TO SECTION 906 (CHIEF EXECUTIVE OFFICER) h56654exv32w1.htm EX-32.1 3285
5 CERTIFICATION PURSUANT TO SECTION 906 (CHIEF FINANCIAL OFFICER) h56654exv32w2.htm EX-32.2 3070
  Complete submission text file 0000950129-08-002919.txt   192245
Mailing Address 2408 TIMBERLOCH PLACE B-7 THE WOODLANDS TX 77380
Business Address 2408 TIMBERLOCH PL SUITE B-7 WOODLANDS TX 77380 2817193400
REPROS THERAPEUTICS INC. (Filer) CIK: 0000897075 (see all company filings)

IRS No.: 760233274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15281 | Film No.: 08820191
SIC: 2836 Biological Products, (No Diagnostic Substances)